Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
06/11/2003 | EP1317669A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
06/11/2003 | EP1317668A1 Method for the pyrolysis of mercuric chloride for the subsequent analysis of the mercury |
06/11/2003 | EP1317565A2 Method for controlling the microbiological quality of an aqueous medium and kit therefor |
06/11/2003 | EP1317564A2 Screening methods to identify g-proteins and other compounds which modulate phosphodiesterase (pde) activity |
06/11/2003 | EP1317563A2 Test-strips with positively charged membranes for tetrazolium based assays |
06/11/2003 | EP1317562A2 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |
06/11/2003 | EP1317554A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
06/11/2003 | EP1317548A2 Transglutaminase gene products |
06/11/2003 | EP1317544A1 Novel diagnostic agents of chronic or persistent chlamydial diseases and uses thereof |
06/11/2003 | EP1317541A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
06/11/2003 | EP1317540A2 Imidazoline receptor homologs |
06/11/2003 | EP1317539A2 Directed evolution method |
06/11/2003 | EP1317536A2 Tnf receptor-like molecules and uses thereof |
06/11/2003 | EP1317531A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
06/11/2003 | EP1317511A1 Oxazine derivatives |
06/11/2003 | EP1317486A1 Interferon-alpha induced gene |
06/11/2003 | EP1317485A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
06/11/2003 | EP1317481A2 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene |
06/11/2003 | EP1317476A2 Reagents for cell selection and methods of use |
06/11/2003 | EP1317464A2 Fluorescent nucleobase conjugates having anionic linkers |
06/11/2003 | EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents |
06/11/2003 | EP1317422A1 Substrate with controlled amine density and regular spacing and method for preparing the same |
06/11/2003 | EP1317278A2 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
06/11/2003 | EP1317275A1 Medicament comprising a dna sequence which codes for the rna-binding koc protein, and comprising a koc protein or a dna sequence of the koc promoter |
06/11/2003 | EP1232393B1 Breath-alcohol measuring instrument |
06/11/2003 | EP1057000A4 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY |
06/11/2003 | EP0979304A4 Detection of endometrial cancer |
06/11/2003 | EP0931254B1 Method of analysis of samples by determination of a function of specific brightness |
06/11/2003 | EP0862742B1 Assay for blood clotting factors viii and ix |
06/11/2003 | EP0848755B1 Vegf-related protein |
06/11/2003 | EP0842410B1 Compositions and methods for the rapid analysis of reticulocytes |
06/11/2003 | EP0782863B1 Antibody reagent for detecting dissecting aortic aneurysm and use thereof |
06/11/2003 | EP0690873B1 Growth differentiation factor-8 |
06/11/2003 | EP0665886B1 Cyclin complex rearrangement and uses related thereto |
06/11/2003 | EP0644900B1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and its use |
06/11/2003 | EP0539492B1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
06/11/2003 | CN2555505Y Integrated fume gas analyzer |
06/11/2003 | CN1423749A Method for the analysis of a selected multicomponent sample |
06/11/2003 | CN1423748A Solution and crystal structures of MMP-13 active sidte and uses thereof |
06/11/2003 | CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex |
06/11/2003 | CN1423697A Virulence genes and proteins and their use |
06/11/2003 | CN1423660A Antibodies |
06/11/2003 | CN1423658A Modulation of human sodium channels in dorsal root ganglia |
06/11/2003 | CN1423563A Pancreatic stem cells and their use in transplantation |
06/11/2003 | CN1423523A Human ex vivo immune system |
06/11/2003 | CN1423131A Composite chip for detecting autoimmune antibody of diabetes mellitus, and preparation and detection method thereof |
06/11/2003 | CN1423130A HLA cross matching method for stream measuring fixed complement antibody and kit thereof |
06/11/2003 | CN1423129A Kit for detecting egg vitellary membrane antibody |
06/11/2003 | CN1423128A 溶液干燥系统 Drying system solution |
06/11/2003 | CN1423121A Measuring device for testing components in water |
06/11/2003 | CN1422963A RET oligo-nucleotide microchip and method for detecting genetic cancer |
06/11/2003 | CN1422864A Zinc finger protein and its antibody preparation and use |
06/11/2003 | CN1422704A System for distributing solution in strip-shape |
06/11/2003 | CN1111283C Process for preparing human placenta lactogen as diagnostic blood corpuscle immunodiffusion plate |
06/11/2003 | CN1111282C Phlegm-treating agent for examining lung cancer cells |
06/10/2003 | US6577958 Surveillant concurrent engineering process tool for environment rendering (SCEPTER) for resin flow monitoring in composites |
06/10/2003 | US6577754 Robust stain detection and quantification for histological specimens based on a physical model for stain absorption |
06/10/2003 | US6577706 Measurement of lateral yarn density distribution |
06/10/2003 | US6577392 Characterization of non-biological polymers using flow-injection analysis with light-scattering detection |
06/10/2003 | US6577143 Apparatus and method for determining a drying time of a piece of wood |
06/10/2003 | US6577141 System and method for capacitance sensing of pavement density |
06/10/2003 | US6577140 Method and device for measuring the acidity or basicity of insulating fluids, particularly mineral and synthetic oils |
06/10/2003 | US6577134 Sensor and sensor system for liquid conductivity, temperature and depth |
06/10/2003 | US6577112 Method and apparatus for on-line monitoring of quality and/or condition of highly resistive fluids |
06/10/2003 | US6576906 Semiconductor candidate materials on a common substrate, separated to avoid interdiffusion between library members; exposing to infrared radiation of varying wavelength, measuring the amount of radiation, R(lambda ), reflected |
06/10/2003 | US6576896 Electroosmotic fluidic device and related methods |
06/10/2003 | US6576811 Transgenic rat with human normal type c-Ha-ras gene |
06/10/2003 | US6576793 β2-adrenergic receptor agonists |
06/10/2003 | US6576759 Antiproliferative agents; anticancer agents; rheumatic disorders; administering nucleotide |
06/10/2003 | US6576756 Nucleotide sequences coding polypetide for use in the diagnosis and treatment of cancer |
06/10/2003 | US6576753 Genomic clone of given sequence; can use in diagnosing susceptibility to asthma |
06/10/2003 | US6576746 Site-specific labeling of disulfide-containing targeting vectors |
06/10/2003 | US6576745 Human cystatin F antibodies |
06/10/2003 | US6576719 Isobutene polymerization process |
06/10/2003 | US6576609 Methods and compositions for generating angiostatin |
06/10/2003 | US6576608 Stimulating tyrosine phosphorylation of Flt4 tyrosine kinase receptor in Flt4-expressing cell |
06/10/2003 | US6576607 Methods using CNS neurite outgrowth modulators |
06/10/2003 | US6576478 Substrate and cover forming closed channels having open ends for loading of the fluid; use in drug screening, clinical diagnostics and parallel screening of families of related proteins |
06/10/2003 | US6576475 Assay system and novel labelled compounds for use therewith |
06/10/2003 | US6576467 Methods for producing recombined antibodies |
06/10/2003 | US6576461 Electrochemical affinity assay |
06/10/2003 | US6576460 Comprising porous membrane having a immobilized binding material; support having opening for passage of test sample; quantify bound analyte; liposomes; electrochemical or optical analysis; can use for rapid hybridization assays |
06/10/2003 | US6576448 Isolating preferential nucleotide sequences; obtain sample of nucleotide sequences, incubate with restriction enzymes, tie adaptors, methylate, denature, methylated incubate with preferential enzymes, elongate, recover sequence |
06/10/2003 | US6576439 Contacting protein of given sequence with a test compound and detecting modulating activity; drug screening; can use for treatment of inflammatory conditions |
06/10/2003 | US6576437 Stimulus-inducible protein kinase complex and methods of use therefor |
06/10/2003 | US6576435 Method for predicting refractory periodontal disease |
06/10/2003 | US6576434 Transport protein of given amino acid sequence; exposing cells that express the protein to compound; measuring ion transport; use in treatment of interleukin mediated atopic allergy, asthma and cystic fibrosis |
06/10/2003 | US6576430 Detection of ligands by refractive surface methods |
06/10/2003 | US6576428 Direct selection of antigen-specific T cells, compositions obtained thereby and methods of use thereof |
06/10/2003 | US6576427 Human cartilage glycoprotein |
06/10/2003 | US6576426 Tag reagent and assay method |
06/10/2003 | US6576423 Detect nucleotide sequences associate with pancreatic cancer; obtain tissue sample, extract nucleotide sequences, incubate with primers, amplify, detect marker gene expression |
06/10/2003 | US6576422 Interaction between marker ligand and ligand binding domain of detector composition (nucleotide sequences encoding transcription factors) produces a detectable signal |
06/10/2003 | US6576419 Assay procedure using fluorogenic tracers |
06/10/2003 | US6576417 Synthetic antigens for the detection of antibodies to hepatitis C virus |
06/10/2003 | US6576416 For use in determining the concentration of chemical and biochemical components in aqueous fluids; determination of blood glucose concentrations |
06/10/2003 | US6576355 Nanotechnology for electronic and opto-electronic devices |
06/10/2003 | US6576259 Sustained release formulations containing tacrolimus |
06/10/2003 | US6576241 Crude drug extracts, and methods for making and standardizing same |
06/10/2003 | US6576240 Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection |